The National Institute of Neurological Disorders and Stroke (NINDS) encourages small business innovation research (SBIR) and small business technology transfer (STTR) applications to develop novel technologies for in vivo imaging. This announcement is made together with 3 other components of the National Institutes of Health (NIH).*
Significant advances in medical imaging technologies have been made in the past 25 years in such areas as magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine, ultrasound, and optical imaging. These advances largely focused on structural or anatomical imaging at the organ or tissue level. Now there is an opportunity to develop and integrate novel imaging technologies that exploit current knowledge of the genetic and molecular bases of various diseases.
Topics of research interest include, but are not limited to: early disease detection; disease screening; imaging for diagnosis, staging, or monitoring the effects of therapy; image-guided biopsy (IGB), image-guided therapy (IGT), and image-guided interventional (IGI) procedures; and copies of prototype imaging systems.
For more information, potential applicants should contact Dr. Daofen Chen, Program Director, Systems and Cognitive Neuroscience Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2131, Bethesda, MD 20892; telephone: 301-496-1917; fax: 301-402-1501; e-mail: email@example.com.
*For a full list of supporting NIH components and a more detailed description of this announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PA-06-046.html (SBIR) or http://grants.nih.gov/grants/guide/pa-files/PA-06-045.html (STTR).